{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:09:30Z","timestamp":1772755770936,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.pupt.2011.12.009","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T07:25:11Z","timestamp":1325834711000},"page":"124-134","source":"Crossref","is-referenced-by-count":17,"title":["Methacholine delays pulmonary absorption of inhaled \u03b22-agonists due to competition for organic cation\/carnitine transporters"],"prefix":"10.1016","volume":"25","author":[{"given":"Mirjam","family":"Gnadt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Trammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Freiwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Kardziev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin K.","family":"Bayliss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris D.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godehard","family":"Friedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"H\u00f6gger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2011.12.009_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1183\/09031936.00138707","article-title":"Global strategy for asthma management and prevention: GINA executive summary","volume":"31","author":"Bateman","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2011.12.009_bib2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2011.12.009_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1517\/13543784.14.7.775","article-title":"Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease","volume":"14","author":"Cazzola","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pupt.2011.12.009_bib4","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1021\/jm801016j","article-title":"Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating arylsulfonamide groups","volume":"52","author":"Procopiou","year":"2009","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.pupt.2011.12.009_bib5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1023\/A:1015951402799","article-title":"A\u00a0method for determination of the absolute pulmonary bioavailability of inhaled drugs: terbutaline","volume":"7","author":"Borgstr\u00f6m","year":"1990","journal-title":"Pharm Res"},{"key":"10.1016\/j.pupt.2011.12.009_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.0306-5251.2001.01374.x","article-title":"Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man","volume":"51","author":"Daley-Yates","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.009_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2125.2004.02238.x","article-title":"Equivalent lung deposition of budesonide in\u00a0vivo: a comparison of dry powder inhalers using a pharmacokinetic method","volume":"59","author":"Lahelma","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.009_bib8","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1014350","article-title":"Effect of bronchoconstriction on airway remodeling in asthma","volume":"364","author":"Grainge","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pupt.2011.12.009_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1465-9921-10-104","article-title":"The bioavailability and airway clearance of the steroid component of budesonide\/formoterol and salmeterol\/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial","volume":"10","author":"Dalby","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.pupt.2011.12.009_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2125.2007.02856.x","article-title":"Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction","volume":"64","author":"Mortimer","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.009_bib11","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1378\/chest.113.6.1573","article-title":"Regional lung deposition and clearance of 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma","volume":"113","author":"Saari","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2011.12.009_bib12","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1164\/rccm.200410-1414OC","article-title":"Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size","volume":"172","author":"Usmani","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2011.12.009_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1465-9921-6-21","article-title":"Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model","volume":"6","author":"Freiwald","year":"2005","journal-title":"Respir Res"},{"issue":"Suppl D","key":"10.1016\/j.pupt.2011.12.009_bib14","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0954-6111(02)80019-1","article-title":"Modulite technology: pharmacodynamic and pharmacokinetic implications","volume":"96","author":"Woodcock","year":"2002","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2011.12.009_bib15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1378\/chest.118.4.1069","article-title":"Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate","volume":"118","author":"Laube","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2011.12.009_bib16","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1378\/chest.128.4.3020","article-title":"Positron emission tomography studies of human airways using an inhaled beta-adrenoceptor antagonist, S-11C-CGP 12388","volume":"128","author":"van Waarde","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2011.12.009_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2125.2002.01632.x","article-title":"Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization","volume":"54","author":"Silkstone","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.009_bib18","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","article-title":"Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications","volume":"24","author":"Koepsell","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.pupt.2011.12.009_bib19","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/jps.21995","article-title":"Drug transporters in the lung\u2013do they play a role in the biopharmaceutics of inhaled drugs?","volume":"99","author":"Bosquillon","year":"2010","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.pupt.2011.12.009_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1165\/rcmb.2006-0230OC","article-title":"Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway","volume":"36","author":"Horvath","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2011.12.009_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1465-9921-6-59","article-title":"ATP-binding cassette (ABC) transporters in normal and pathological lung","volume":"6","author":"van der Deen","year":"2005","journal-title":"Respir Res"},{"key":"10.1016\/j.pupt.2011.12.009_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pupt.2004.11.007","article-title":"Salbutamol is actively absorbed across human bronchial epithelial cell layers","volume":"18","author":"Ehrhardt","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pupt.2011.12.009_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/mp900206j","article-title":"Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation\/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption","volume":"7","author":"Nakamura","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pupt.2011.12.009_bib24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/mol.59.2.358","article-title":"Molecular and physiological evidence for multifunctionality of carnitine\/organic cation transporter OCTN2","volume":"59","author":"Ohashi","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.009_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1465-9921-7-65","article-title":"Role of acetylcholine and polyspecific cation transporters in serotonin-induced bronchoconstriction in the mouse","volume":"7","author":"Kummer","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.pupt.2011.12.009_bib26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s002280000233","article-title":"Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions","volume":"56","author":"Kirby","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.009_bib27","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1177\/0091270008322122","article-title":"Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD","volume":"48","author":"Tronde","year":"2008","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.pupt.2011.12.009_bib28","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2007.08.034","article-title":"The effect of corticosteroids on the disposal of long-acting beta2-agonists by airway smooth muscle cells","volume":"120","author":"Horvath","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553912000028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553912000028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T04:08:14Z","timestamp":1561176494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553912000028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1094553912000028"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2011.12.009","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}